Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDORMS announces the closure of the Kennedy and Botnar Institutes and outlines other plans and activities for the department during the pandemic.

Coronavirus close up © Shutterstock

Regretfully, we are announcing the closure of the Kennedy and Botnar Institutes effective from noon on Wednesday 25 March. The Kadoorie Centre based at the John Radcliffe Hospital will remain open for staff working in clinical roles in the NHS and for essential follow-up of patients already recruited into clinical studies.

Many of our staff and postgraduate students will be continuing their day-to-day work from home, while others may take on or extend a clinical role to support the NHS in the fight against COVID-19. Some of our research teams are working towards solutions to contain the spread of coronavirus and we will share updates on this as we have them.

All new clinical research will be put on hold and recruitment of new participants to our clinical studies in Oxford will be paused.

For students, teaching and learning in Trinity term will be moved to an online format where possible, and there will be no conventional written paper exams. Detailed planning continues but our aim throughout is to ensure students can continue, or complete, their academic careers at Oxford. Most of our scheduled workshops/modules for postgraduate research students have been postponed and students are being advised to keep in touch with their supervisors.

Professor Andrew Carr, Head of Department said: "Researchers at NDORMS and across Oxford are at the forefront of global efforts to understand this coronavirus (COVID-19) and protect our communities.

I would like to thank all our teams at NDORMS who are supporting these efforts and the very responsible and collegiate way in which you have responded to this unprecedented situation. It is very stressful and disruptive for everyone particularly those with extra risk factors. In addition, many members of the department have family members and loved ones who are at high risk and many live in other countries where restrictions to travel make visits impossible."

The University of Oxford COVID-19 research hub features regular updates about the latest research publications and longer-form pieces covering the many ways Oxford is approaching this pandemic: www.ox.ac.uk/coronavirus-research.

Funding for Oxford's COVID-19 research requires unprecedented speed, scope and ambition and anyone wishing to fund the university's efforts can donate here: http://www.ox.ac.uk/coronavirus-research/support

For more information please contact communications@ndorms.ox.ac.uk in the first instance, and we can direct your enquiry to the appropriate team.

Similar stories

Patient and public involvement in Rheumatology research – embracing the wave of change

On launching the new OPEN ARMS PPI group in Oxford, Dr. Laura Coates explored the patient and public involvement (PPI) models of three academic centres in the UK to show how it benefits researchers, clinicians, and patients alike.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

NDORMS joins research partnership to understand links between overlapping long-term conditions

The links between different long-term health conditions will be explored in new research funded with a £2.5million grant from the Medical Research Council.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Researchers show the role of cilia in cartilage health

New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.

New research could improve quality of life for Psoriatic Arthritis patients

Professors Laura Coates and Dani Prieto-Alhambra will take major roles in a new European Commission project to develop innovative personalised treatment options for people affected by psoriatic arthritis.